Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.67 -0.15 (-0.36%)
As of: Sep 30, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Cash from Operations (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) recorded Cash from Operations of $411 million in Q2 2026, up 81.1% from $227 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Cash from Operations (2009 - 2026) Analysis & Trends

On a TTM basis, Teva Pharmaceutical Industries' Cash from Operations came in at $1.9 billion as of Jun 30, 2026, up 36.5% year-over-year; for FY2025, it came in at $1.65 billion, up 32.2% from FY2024.

  • Annual Cash from Operations has a five-year compound annual growth rate of 6.3% (FY2020 to FY2025).
  • Across earlier years, Cash from Operations came in at $1.25 billion in FY2024 (-8.8%), $1.37 billion in FY2023 (-14.0%), $1.59 billion in FY2022 (+99.2%) and $798 million in FY2021 (-34.4%).
  • Quarterly Cash from Operations has ranged from -$145 million in Q1 2023 to $1.18 billion in Q4 2023 over the past five years.
  • On a year-over-year basis, Cash from Operations rose in three of the last five quarters, with growth averaging 40.9%.
  • Peak year-over-year performance for Cash from Operations in the last five years was growth of 163.4% in Q2 2023, against a decline of 99.1% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$40 million (Q1 2026), $1.16 billion (Q4 2025) and $369 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 8.62 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.44 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 4.58 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 3.57 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.13 Bn
10 Teva Pharmaceutical Industries 46.38 Bn 33.23 Bn 2.15 Bn 411.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 411.00 Mn
Mar 31, 2026 -40.00 Mn
Dec 31, 2025 1.16 Bn
Sep 30, 2025 369.00 Mn
Jun 30, 2025 227.00 Mn
Mar 31, 2025 -105.00 Mn
Dec 31, 2024 575.00 Mn
Sep 30, 2024 693.00 Mn
Jun 30, 2024 103.00 Mn
Mar 31, 2024 -124.00 Mn
Dec 31, 2023 1.18 Bn
Sep 30, 2023 5.00 Mn
Jun 30, 2023 324.00 Mn
Mar 31, 2023 -145.00 Mn
Dec 31, 2022 973.00 Mn
Sep 30, 2022 543.00 Mn
Jun 30, 2022 123.00 Mn
Mar 31, 2022 -49.00 Mn
Dec 31, 2021 456.00 Mn
Sep 30, 2021 529.00 Mn
API Access

Teva Pharmaceutical Industries Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=TEVA&period=max&api_key=YOUR_API_KEY